PROCEPT BioRobotics (PRCT) Gross Margin (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Gross Margin data on file, last reported at 64.89% in Q1 2026.

• On a quarterly basis, Gross Margin rose 104.0% year-over-year to 64.89% in Q1 2026; TTM through Mar 2026 was 63.97%, a 126.0% increase from a year earlier, with the FY2025 full-year figure at 63.7%, up 263.0% from the prior year.
• Gross Margin for Q1 2026 stood at 64.89%, up from 60.63% in the prior quarter.
• Over the last five years, Gross Margin for PRCT reached as high as 65.35% in Q2 2025 and fell as low as 44.9% in Q4 2022.
• Historically, Gross Margin has averaged 57.15% across 5 years, with a median of 56.21% in 2024.
• Across the five-year window, Gross Margin soared 1523 bps in 2024 and plunged 337 bps in 2025, its largest moves.
• Year by year, Gross Margin stood at 44.9% in 2022, then increased by 9 bps to 48.77% in 2023, then surged by 31 bps to 64.0% in 2024, then retreated by 5 bps to 60.63% in 2025, then increased by 7 bps to 64.89% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 64.89% in Q1 2026, 60.63% in Q4 2025, and 64.81% in Q3 2025.